Estimates Revisions Regeneron Pharmaceuticals, Inc. Sao Paulo
Stocks
REGN34
BRREGNBDR005
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.05 BRL | -0.46% |
|
+1.03% | -23.78% |
| 11:33am | MLCC Prices Surge as AI Supply Chain Faces New Bottleneck |  |
| 06-30 | Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
- Consensus Regeneron Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
